Yahoo Canada Web Search

Search results

1. www.abbott.com › corpnewsroom › strategy-andAbbott Q4 Earnings: Continued Resiliency | Abbott Newsroom

   www.abbott.com › corpnewsroom › strategy-and

   • Cached

   Jan 25, 2023 · For the quarter: For the full year: Abbott issued full-year guidance for 2023 adjusted diluted EPS from continuing operations of $4.30 to $4.50. 3. These are the key fourth-quarter highlights: Sales of FreeStyle Libre systems exceeded $1 billion with U.S. sales growing more than 40%.

2. dam.abbott.com › en-us › hubFOURTH-QUARTER AND FULL-YEAR 2022 RESULTS - Abbott Laboratories

   dam.abbott.com › en-us › hub

   ul. -year 2022 GAAP diluted EPS was $3.91. 3. ou. th-quarter GAAP diluted EPS was $0.59. 4. Abbott projected full-year 2022 dilu. ed. EPS on a GAAP basis of $3.75 to $3.81. 5. Abbott projects full-year 2023 diluted earnings per share from continuin. operations under GAAP of $3.05 to $3.25. Abbott forecasts specified items for the full-year 2023 ...

3. seekingalpha.com › article › 4572315-abbottAbbott Laboratories (ABT) Q4 2022 Earnings Call Transcript

   seekingalpha.com › article › 4572315-abbott

   Jan 25, 2023 · EPS of $1.03 beats by $0.09 | Revenue of $10.09B(-12.01% Y/Y)beats by $367.99M. Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Conference Call January 25, 2023 9:00 AM ET. Company Participants ...

4. www.prnewswire.com › news-releases › abbott-reportsAbbott Reports Fourth-Quarter and Full-Year 2022 Results ...

   www.prnewswire.com › news-releases › abbott-reports

   • Cached

   Jan 25, 2023 · Abbott. Jan 25, 2023, 07:30 ET. Fourth-quarter sales of $10.1 billion; full-year 2022 sales of $43.7 billion. Full-year 2022 sales growth of 1.3 percent; organic sales growth of 6.4 percent. Full ...

5. last10k.com › sec-filings › abtAbbott Laboratories (ABT) 10-K Annual Report February 2022

   last10k.com › sec-filings › abt

   Feb 18, 2022 · Abbott issues full-year 2022 guidance for diluted EPS from continuing operations on a GAAP basis of at least $3.43 and full-year adjusted diluted EPS from continuing operations of at least $4.70. Full-year 2022 guidance includes an initial COVID-19 testing-related sales forecast of $2.5 billion, which Abbott expects to occur early in the year and will update on a quarterly basis.

6. dam.abbott.com › en-us › hubFIRST-QUARTER 2022 RESULTS - Abbott Laboratories

   dam.abbott.com › en-us › hub

   Abbott forecasts specified items for the full-year 2022 of $1.35 per share primarily related to intangible amortization, costs related to a voluntary recall, expenses associated with acquisitions, restructurings and cost reduction initiatives, and other net expenses. Excluding specified items, projected adjusted diluted earnings per share of at ...

7. People also ask

   How did Abbott perform in January 2022?

   • Abbott significantly exceeded guidance issued in January 2022, continues strengthening product portfolio. Combine Abbott's diverse business portfolio with a steady drumbeat of new product approvals and what do you get? A solid full-year financial performance and momentum going forward.

   Abbott Q4 Earnings: Continued Resiliency | Abbott Newsroom

   www.abbott.com/corpnewsroom/strategy-and-strength/Abbott-Q4-earnings-continued-resiliency.html

   See all results for this question

   What does Abbott expect in 2023?

   • 5. Abbott projects full-year 2023 diluted earnings per share from continuing operations under GAAP of $3.05 to $3.25. Abbott forecasts specified items for the full-year 2023 of $1.25 per share primarily related to intangible amortization, restructuring and cost reduction initiatives and other net expenses.

   FOURTH-QUARTER AND FULL-YEAR 2022 RESULTS - Abbott Laboratories

   dam.abbott.com/en-us/hub/4Q22-Earnings-Infographic-FINAL.pdf

   See all results for this question

   What are Abbott's forecasts for full-year 2023?

   • Abbott forecasts full-year 2023 diluted earnings per share from continuing operations under GAAP of $3.05 to $3.25. They also project specified items for the full-year 2023 of $1.25 per share, primarily related to intangible amortization, restructuring and cost reduction initiatives, and other net expenses.

   Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023

   www.prnewswire.com/news-releases/abbott-reports-fourth-quarter-and-full-year-2022-results-issues-2023-financial-outlook-301730346.html

   See all results for this question

   What does Abbott forecast for 2022?

   • Abbott forecasts specified items for the full-year 2022 of $1.35 per share primarily related to intangible amortization, costs related to a voluntary recall, expenses associated with acquisitions, restructurings and cost reduction initiatives, and other net expenses.

   TOTAL COMPANY BUSINESS HIGHLIGHTS $11.9B +17.5% 1 INNOVATIO…

   dam.abbott.com/en-us/hub/ABT-1Q22-Earnings-Infographic-FINAL.pdf

   See all results for this question

   What are Abbott's expected earnings per share in 2023?

   • Abbott forecasts $4.30 to $4.50 for its adjusted diluted earnings per share from continuing operations in the full-year 2023.

   Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023

   www.prnewswire.com/news-releases/abbott-reports-fourth-quarter-and-full-year-2022-results-issues-2023-financial-outlook-301730346.html

   See all results for this question

   What were Abbott's Q4 results?

   • For the quarter: For the full year: Abbott issued full-year guidance for 2023 adjusted diluted EPS from continuing operations of $4.30 to $4.50. 3 These are the key fourth-quarter highlights: Sales of FreeStyle Libre systems exceeded $1 billion with U.S. sales growing more than 40%.

   Abbott Q4 Earnings: Continued Resiliency | Abbott Newsroom

   www.abbott.com/corpnewsroom/strategy-and-strength/Abbott-Q4-earnings-continued-resiliency.html

   See all results for this question

8. www.nasdaq.com › articles › abbotts-abt-q4-earningsAbbott's (ABT) Q4 Earnings and Revenues Beat Estimates

   www.nasdaq.com › articles › abbotts-abt-q4-earnings

   • Cached

   Jan 26, 2022 · January 26, 2022 — 10:47 am EST. Written by Zacks Equity Research for Zacks -> Abbott Laboratories ABT reported fourth-quarter 2021 adjusted earnings from continuing operations of $1.32 per ...